NEW YORKER’S BECOME DHL WALKING EXPERIMENT

AUTHOR’S NOTE:  ALL I CAN SAY IS ANYONE WITH SERIOUS UPPER RESPIRATORY  HEALTH ISSUES STAY THE HELL AWAY FROM THESE AREAS.  HMMM, WHO WOULD OF THOUGHT OUR GOVERNMENT WOULD USE AMERICANS AS “WALKING EXPERIMENTS!”  BELOW ARE LINKS TO THE DHL DOCUMENTS ON THEIR SITE IN PDF FORMAT.  MY SUGGESTION:  DOWNLOAD THESE BAD BOYS AND SHOW THEM TO YOUR DOCTOR!!

Environmental Assessment of Proposed NYC Subway Tracer Particle and Gas Releases for the Underground Transport Restoration (UTR) ProjecT

IF YOU ARE INTERESTED!

DHS QUADRENNIAL HOMELAND SECURITY REVIEW 2014-2018

FDA ALERT

On May 16, 2016, the Food and Drug Administration (FDA) issued a draft guidance for industry “Use of Electronic Health Record Data in Clinical Investigations.”  The draft guidance is intended to assist sponsors, clinical investigators, contract research organizations, institutional review boards (IRBs), and other interested parties on the use of electronic health record (EHR) data in FDA-regulated clinical investigations. The guidance aims to facilitate use of electronic health record (EHR) data in clinical investigations and to promote the interoperability of EHRs and electronic systems supporting the clinical investigation.

Please see the Notice of Availability (NOA) for information on how to submit comments on the draft guidance.

For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.

For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.